Filippseyjar - enska - FDA (Food And Drug Administration)

qualimed pharma, inc.; distributor: qualimed pharma, inc. - vinblastine sulfate - powder for injection (i.v.) - 10 mg

Filippseyjar - enska - FDA (Food And Drug Administration)

qualimed pharma, inc.; distributor: qualimed pharma, inc. - ifosfamide - powder for injection (i.v./i.v. infusion) - 2 g

Filippseyjar - enska - FDA (Food And Drug Administration)

qualimed pharma, inc.; distributor: qualimed pharma, inc. - oxaliplatin - lyophilized powder for injection (i.v. infusion) - 100 mg

Bandaríkin - enska - NLM (National Library of Medicine)

qualitest pharmaceuticals - potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152, chloride ion - unii:q32zn48698), potassium bicarbonate (unii: hm5z15lebn) (potassium cation - unii:295o53k152), lysine hydrochloride (unii: jnj23q2com) (lysine - unii:k3z4f929h6) - potassium chloride 1.25 g - indications and usage: 1. for therapeutic use in patients with hypokalemia with or without metabolic alkalosis, in digitalis intoxication and in patients with hypokalemic familial periodic paralysis. 2. for prevention of potassium depletion when the dietary intake of potassium is inadequate in the following conditions: patients receiving digitalis and diuretics for congestive heart failure; hepatic cirrhosis with ascities; states of aldosterone excess with normal renal function; potassium-losing nephropathy, and certain diarrheal states. 3. the use of potassium salts in patients receiving diuretics for uncomplicated essential hypertension is often unnecessary when such patients have a normal dietary pattern. serum potassium should be checked periodically, however, and, if hypokalemia occurs, dietary supplementation with potassium-containing foods may be adequate to control milder cases. in more severe cases supplementation with potassium salts may be indicated. contraindications: potassium supp

Bandaríkin - enska - NLM (National Library of Medicine)

a-s medication solutions - lactulose (unii: 9u7d5qh5ae) (lactulose - unii:9u7d5qh5ae) - lactulose 10 g in 15 ml - for the treatment of constipation. in patients with a history of chronic constipation, lactulose solution therapy increases the number of bowel movements per day and the number of days on which bowel movements occur. since lactulose solution contains galactose (less than 1.6 g/15 ml), it is contraindicated in patients who require a low galactose diet.

Kanada - enska - Health Canada

zoetis canada inc - gonadotropin-releasing factor analog-diphtheria toxoid conjugate - solution - 0.2mg - gonadotropin-releasing factor analog-diphtheria toxoid conjugate 0.2mg - swine (pigs)

Kanada - enska - Health Canada

parnell technologies pty ltd - cloprostenol (cloprostenol sodium) - solution - 250mcg - cloprostenol (cloprostenol sodium) 250mcg - cattle

Armenía - enska - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

hameln pharmaceuticals gmbh - granisetron (granisetron hydrochloride) - concentrate for solution for injection/infusion - 1mg/ml

Kanada - enska - Health Canada

zoetis canada inc - bedinvetmab - solution - 5mg - bedinvetmab 5mg - dogs